Cleared Traditional

Elecrtronic Blood Pressure Monitor (BP-201, BP-202, BP-203, BP-204, BP-205, BP-206) (K241613) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K241613 · Shenzhen Hbcare Technology Co.,Ltd · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2024
Decision
133d
Days
Class 2
Risk

K241613 is an FDA 510(k) clearance for the Elecrtronic Blood Pressure Monitor (BP-201, BP-202, BP-203, BP-204, BP-205, B.... Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Shenzhen Hbcare Technology Co.,Ltd (Shenzhen, CN). The FDA issued a Cleared decision on October 16, 2024 after a review of 133 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Shenzhen Hbcare Technology Co.,Ltd devices

Submission Details

510(k) Number K241613 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 05, 2024
Decision Date October 16, 2024
Days to Decision 133 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d slower than avg
Panel avg: 125d · This submission: 133d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 281
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K241613.
Arm Blood Pressure Monitor (model: BPM-A7VL)
K243118 · Shenzhen Imdk Medical Technology Co., Ltd. · Nov 2024
Upper Arm Electronic Blood Pressure Monitor (U86E and TelliBP01)
K241007 · Shenzhen Urion Technology Co., Ltd. · Oct 2024
Arm Type Blood Pressure Monitor (BPM82)
K242193 · Avita Corporation · Oct 2024
Upper Arm Electronic Blood Pressure Monitor (FC-BP103, FC-BP106, FC-BP113, FC-BP120, FC-BP121, FC-BP130, FC-BP131)
K242721 · Shenzhen Finicare Co., Ltd. · Oct 2024
Blood Pressure Monitor (TMB-2092-G)
K241351 · Guangdong Transtek Medical Electronics Co., Ltd. · Aug 2024
Upper Arm Electronic Blood Pressure Monitor
K241129 · Shenzhen Goodlymed Technology Co., Ltd. · Jul 2024